Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 308

1.

Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality.

Bulluck H, Maiti R, Chakraborty B, Candilio L, Clayton T, Evans R, Jenkins DP, Kolvekar S, Kunst G, Laing C, Nicholas J, Pepper J, Yellon DM, Hausenloy DJ.

Heart. 2017 Aug 9. pii: heartjnl-2017-311760. doi: 10.1136/heartjnl-2017-311760. [Epub ahead of print]

PMID:
28794136
2.

Body mass index and vigorous physical activity in children and adolescents: an international cross-sectional study.

Braithwaite IE, Stewart AW, Hancox RJ, Murphy R, Wall CR, Beasley R, Mitchell EA; ISAAC Phase Three Study Group.

Acta Paediatr. 2017 Aug;106(8):1323-1330. doi: 10.1111/apa.13903. Epub 2017 Jun 6.

PMID:
28471494
3.

Distinguishing between those dying suddenly or not suddenly from coronary heart disease: long-term prospective results from the Northwick Park Heart Study.

Meade T, Clayton T, Chamberlain D.

Open Heart. 2016 Dec 5;3(2):e000440. doi: 10.1136/openhrt-2016-000440. eCollection 2016.

4.

Impact of call-to-balloon time on 30-day mortality in contemporary practice.

Varcoe RW, Clayton TC, Gray HH, de Belder MA, Ludman PF, Henderson RA; British Cardiovascular Intervention Society (BCIS) and the National Institute for Cardiovascular Outcomes Research (NICOR).

Heart. 2017 Jan 15;103(2):117-124. doi: 10.1136/heartjnl-2016-309658. Epub 2016 Jul 13.

PMID:
27411838
5.

Effect of Remote Ischaemic preconditioning on Clinical outcomes in patients undergoing Coronary Artery bypass graft surgery (ERICCA study): a multicentre double-blind randomised controlled clinical trial.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas JM, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM.

Southampton (UK): NIHR Journals Library; 2016 Jun.

6.

Description of artefacts in the PowerPlex Y23(®) system associated with excessive quantities of background female DNA.

Moore D, Clayton T, Thomson J.

Forensic Sci Int Genet. 2016 Sep;24:44-50. doi: 10.1016/j.fsigen.2016.05.009. Epub 2016 May 19.

PMID:
27288717
7.

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study.

Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, Minassian C, Langan SM.

Neurology. 2016 Jul 5;87(1):94-102. doi: 10.1212/WNL.0000000000002808. Epub 2016 Jun 10.

8.

Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?

Henderson RA, Jarvis C, Clayton T, Pocock SJ, Fox KA.

J Am Coll Cardiol. 2016 Mar 29;67(12):1502-3. doi: 10.1016/j.jacc.2015.12.064. No abstract available.

9.

A 10-year prognostic model for patients with suspected angina attending a chest pain clinic.

Sekhri N, Perel P, Clayton T, Feder GS, Hemingway H, Timmis A.

Heart. 2016 Jun 1;102(11):869-75. doi: 10.1136/heartjnl-2015-308994. Epub 2016 Feb 29.

10.

Reply: Survival Differences in Clinical Trials With Long-Term Follow-up.

Henderson RA, Jarvis C, Clayton T, Pocock SJ, Fox KA.

J Am Coll Cardiol. 2016 Feb 9;67(5):601. doi: 10.1016/j.jacc.2015.10.087. No abstract available.

11.

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.

Ling TC, Clayton TH, Crawley J, Exton LS, Goulden V, Ibbotson S, McKenna K, Mohd Mustapa MF, Rhodes LE, Sarkany R, Dawe RS.

Br J Dermatol. 2016 Jan;174(1):24-55. doi: 10.1111/bjd.14317. No abstract available.

PMID:
26790656
12.

Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial.

Costa RA, Abizaid A, Mehran R, Schofer J, Schuler GC, Hauptmann KE, Magalhães MA, Parise H, Grube E; BioFreedom FIM Clinical Trial Investigators.

JACC Cardiovasc Interv. 2016 Jan 11;9(1):51-64. doi: 10.1016/j.jcin.2015.09.008.

13.

Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials.

Pocock SJ, Clayton TC, Stone GW.

J Am Coll Cardiol. 2015 Dec 29;66(25):2886-98. doi: 10.1016/j.jacc.2015.10.051. Review.

14.

Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials.

Pocock SJ, Clayton TC, Stone GW.

J Am Coll Cardiol. 2015 Dec 22;66(24):2757-66. doi: 10.1016/j.jacc.2015.10.036. Review.

15.

A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.

Clayton T, Poe MM, Rallapalli S, Biawat P, Savić MM, Rowlett JK, Gallos G, Emala CW, Kaczorowski CC, Stafford DC, Arnold LA, Cook JM.

Int J Med Chem. 2015;2015:430248. doi: 10.1155/2015/430248. Epub 2015 Nov 10. Review.

16.

Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.

Yu J, Mehran R, Clayton T, Gibson CM, Brodie BR, Witzenbichler B, Lincoff AM, Deliargyris EN, Gersh BJ, Pocock SJ, Stone GW, Dangas GD.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):391-400. doi: 10.1002/ccd.26146. Epub 2015 Dec 1.

PMID:
26624854
17.

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.

Weisz G, Généreux P, Iñiguez A, Zurakowski A, Shechter M, Alexander KP, Dressler O, Osmukhina A, James S, Ohman EM, Ben-Yehuda O, Farzaneh-Far R, Stone GW; RIVER-PCI investigators.

Lancet. 2016 Jan 9;387(10014):136-45. doi: 10.1016/S0140-6736(15)00459-6. Epub 2015 Oct 22.

PMID:
26474810
18.

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.

Wedgeworth E, Glover M, Irvine AD, Neri I, Baselga E, Clayton TH, Beattie PE, Bjerre JV, Burrows NP, Foelster-Holst R, Hedelund L, Hernandez-Martin A, Audrain H, Bhate K, Brown SJ, Baryschpolec S, Darne S, Durack A, Dvorakova V, Gach J, Goldstraw N, Goodyear H, Grabczynska S, Greenblatt D, Halpern J, Hearn RM, Hoey S, Hughes B, Jayaraj R, Johansson EK, Lam M, Leech S, O'Regan GM, Morrison D, Porter W, Ramesh R, Schill T, Shaw L, Taylor AE, Taylor R, Thomson J, Tiffin P, Tsakok M, Janmohamed SR, Laguda B, McPherson T, Oranje AP, Patrizi A, Ravenscroft JC, Shahidullah H, Solman L, Svensson A, Wahlgren CF, Hoeger PH, Flohr C.

Br J Dermatol. 2016 Mar;174(3):594-601. doi: 10.1111/bjd.14233. Epub 2015 Dec 26.

PMID:
26473312
19.

Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Hausenloy DJ, Kharbanda R, Rahbek Schmidt M, Møller UK, Ravkilde J, Okkels Jensen L, Engstrøm T, Garcia Ruiz JM, Radovanovic N, Christensen EF, Sørensen HT, Ramlall M, Bulluck H, Evans R, Nicholas J, Knight R, Clayton T, Yellon DM, Bøtker HE.

Eur Heart J. 2015 Aug 1;36(29):1846-8.

PMID:
26460398
20.

Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators.

N Engl J Med. 2015 Oct 8;373(15):1408-17. doi: 10.1056/NEJMoa1413534. Epub 2015 Oct 5.

Supplemental Content

Loading ...
Support Center